Subscribe to eTOC

Artificial Intelligence Identifies Early Ischemia on Non-contrast CT

In this video, Matthew Hart, MD, discusses a report on teleneurology—finding it improved access to neurologist appointments and reduced wait times in the emergency department—with Neurology Today editor-in-chief Joseph E. Safdieh, FAAN. He presented the findings at the 2022 AAN Annual Meeting. For the full report, visit https://bit.ly/AANAM-teleneurology.


Recent Videos

Child Neurology Society: Disparities in Treatment for Infantile Spasms
Child Neurology Society: Disparities in Treatment for Infantile Spasms

Legend: Watch this video on disparities in treatment for infantile spasms: Neurology Today Editorial Board Member Ann Tilton, MD, FAAN, interviews Fiona M. Baumer, MD, a pediatric neurologist at Stanford. In a platform presentation at the Child Neurology Society annual meeting, Dr. Baumer presented new data showing disparities in treatment for infantile spasms between Black and White children. Whether they had public or private insurance seemed to be associated with the treatment they received.  For more on the findings, visit https://bit.ly/3lIvzzi

Duration: 9:10

Associated with:

Published on: 10.28.2021

Child Neurology Society: Pain Relief for Treatment-Refractory Pediatric Headaches
Child Neurology Society: Pain Relief for Treatment-Refractory Pediatric Headaches

Legend: Watch this video on a novel pain management approach for treatment-refractory pediatric headaches. Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, interviews Sara Pavitt, MD. about her poster  presentation at the Child Neurology Society annual meeting. Dr. Pavitt presented new data showing that children with refractory headache disorders experienced pain relief when treated with intravenous sodium valproate that included a three- to four-day hospitalization.  For more on the findings, visit https://bit.ly/3aFm51M

Duration: 5:06

Associated with:

Published on: 10.28.2021

Child Neurology Society: Gene Therapy for Cerebral Adrenoleukodystrophy
Child Neurology Society: Gene Therapy for Cerebral Adrenoleukodystrophy

Legend: Watch this video on a novel gene therapy for cerebral adrenoleukodystrophy: Neurology Today Editorial Board member Temitayo Oyegbile-Chidi, MD, PhD, interviews Florian Eichler, MD, about his platform presentation at the Child Neurology Society annual meeting. Dr. Eichler presented new data showing that neurologic function stabilized in boys with cerebral adrenoleukodystrophy who received elivaldogene autotemcel, a novel lenti-D vector gene therapy.  For more on the findings, visit https://bit.ly/3oYQoZz

Duration: 7:14

Associated with:

Published on: 10.28.2021

A Mentoring Program Is a Draw for Underrepresented Students
A Mentoring Program Is a Draw for Underrepresented Students

Legend: Neurology Today At the American Academy of Neurology Annual Meeting: A mentoring program that provides support for research and education on neurology as early as high school could potentially be a powerful tool for increasing interest in the specialty among underrepresented students. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews Madison Ellin, MS, a program coordinator at Massachusetts General Hospital in Boston, about the program.

Read the full report with Neurology Today At the Meetings: https://bit.ly/3eBeuD1

Duration: 3:07

Associated with:

Published on: 04.29.2021

Efgartigimod Was Well-Tolerated in Patients with Generalized Myasthenia Gravis
Efgartigimod Was Well-Tolerated in Patients with Generalized Myasthenia Gravis

Legend: Neurology Today At the American Academy of Neurology Annual Meeting: ​Efgartigimod was safe and effective for patients with generalized myasthenia gravis. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews James F. Howard Jr, MD, FAAN, professor of neurology at the University of North Carolina in Chapel Hill, about the clinical implications of the research. Read the full report: https://bit.ly/3avecwb.

Duration: 6:03

Associated with:

Published on: 04.26.2021

Cenobamate Shows Long-Term Benefits for Focal Seizures
Cenobamate Shows Long-Term Benefits for Focal Seizures

Legend: Neurology Today At the American Academy of Neurology Annual Meeting: Cenobamate leads to sustained, long-term seizure freedom from focal epilepsy in many patients who were refractory to other treatments. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews Michael Sperling, MD, FAAN, professor of neurology at Thomas Jefferson University, about the clinical implications of the research. Read the full report with Neurology Today At the Meetings: https://bit.ly/3sMgH3z.

Duration: 6:14

Associated with:

Published on: 04.23.2021

Atogepant Reduces Number of Mean Monthly Migraines
Atogepant Reduces Number of Mean Monthly Migraines

Legend: Neurology Today At the American Academy of Neurology Annual Meeting: People with migraine who took atogepant, an orally administered calcitonin gene-related peptide receptor antagonist, had an average of three to four fewer migraines each month. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews Jessica Ailani, MD, FAAN, director of MedStar Georgetown Headache Center and professor of clinical neurology in the department of neurology at Medstar Georgetown University in Washington, DC, about the clinical implications of the research. Read the full report with Neurology Today At the Meetings: https://bit.ly/3dBUNvm.

Duration:

Associated with:

Published on: 04.23.2021

Estrogen-Modulating Therapies Associated with Lower Risk of Dementia in Breast Cancer Patients
Estrogen-Modulating Therapies Associated with Lower Risk of Dementia in Breast Cancer Patients

Legend: Neurology Today At the American Academy of Neurology Annual Meeting: Women with breast cancer who were taking tamoxifen and steroidal aromatase inhibitors had a decreased risk for a neurogenerative disease, specifically Alzheimer's disease and dementia. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews Gregory Branigan, a graduate student researcher at the University of Arizona College of Medicine, about the clinical implications of the research. Read the full report with Neurology Today At the Meetings: https://bit.ly/3sye70E.

Duration: 4:00

Associated with:

Published on: 04.21.2021

COVID19: Wellness Strategies
COVID19: Wellness Strategies

Legend: COVID-19: In this video, Joseph E. Safdieh, MD, FAAN, and Jennifer Bickel, MD, FAAN, FAHS, discuss the current state of neurologists’ wellbeing in the setting of COVID-19, the need for community, the power of gratitude, and strategies for recognizing distress and encouraging wellness. For more coverage on these issues, read “The Emotional Fallout of the Pandemic on Our Neurology Workforce” and “The Neurologists Are Not Alright,” a call to action from the editors of Neurology Today.

Duration: 10:23

Associated with: Neurology Today. 21(2):18-19, January 21, 2021 Neurology Today. 21(2):18, January 21, 2021

Published on: 02.04.2021

COVID19: Burnout/Wellness Strategies for Neurologists
COVID19: Burnout/Wellness Strategies for Neurologists

Legend:

COVID-19: Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, and Neil A. Busis, MD, FAAN, discuss the impact of COVID-19 on burnout and strategies to address it. For more coverage on these issues, read “The Emotional Fallout of the Pandemic on Our Neurology Workforce” and “The Neurologists Are Not Alright,” a call to action from the editors of Neurology Today.

Duration: 8:23

Associated with: Neurology Today. 21(2):18-19, January 21, 2021 Neurology Today. 21(2):18, January 21, 2021

Published on: 02.02.2021

COVID-19: Separating Fact from Fiction – An Update
COVID-19: Separating Fact from Fiction – An Update

Legend: COVID-19: In this video, Sherry H-Y. Chou, MD, M.Sc, FNCS, FCCM, joins Richard S. Isaacson, MD, FAAN, for an update on the Global Consortium to Study Neurological Dysfunction in COVID-19. They discuss the progress of the consortium, questions that remain as the COVID-19 pandemic continues, and the goals and outcomes for the research.

Duration: 28:13

Associated with:

Published on: 09.19.2020

Health Care Provider Burnout in the Era of COVID-19
Health Care Provider Burnout in the Era of COVID-19

Legend: COVID-19: Richard S. Isaacson, MD, FAAN, and Neil A. Busis, MD, FAAN, discuss physician burnout, how burnout is changing for health care workers, the increase in institutional wellness programs, and the impact of telemedicine in the setting of COVID-19.

Duration: 24:18

Associated with:

Published on: 07.28.2020

COVID-19: Health Care Disparities
COVID-19: Health Care Disparities

Legend: COVID-19: Richard S. Isaacson, MD, FAAN and Richard T. Benson, MD, PhD, discuss why COVID-19 is disproportionately affecting minorities communities, how the NIH is dealing with the health care disparities across the US, and ways AAN members can address these disparities within their institutions. .

Duration: 25:03

Associated with:

Published on: 07.28.2020

COVID-19: Leading During a Crisis
COVID-19: Leading During a Crisis

Legend: COVID-19: Richard S. Isaacson, MD, FAAN, and Rachel Marie E. Salas, MD, MEd, FAAN, discuss how to lead others by being adaptive, the importance of getting a good night’s rest, and the tools leaders in neurology are relying on amid the COVID-19 pandemic.

Duration: 20:20

Associated with:

Published on: 07.28.2020

COVID-19: Wellness in the Age of COVID-19_Meditation
COVID-19: Wellness in the Age of COVID-19_Meditation

Legend: COVID-19: Richard S. Isaacson, MD, FAAN and transcendental meditation expert, Bob Roth discuss forms of meditation to manage the ongoing trauma and stress health care workers are dealing with in the setting of COVID-19.

Duration: 34:09

Associated with:

Published on: 07.28.2020

COVID19: Online Learning Opportunities from the AAN
COVID19: Online Learning Opportunities from the AAN

Legend: COVID-19: In this video, Richard S. Isaacson, MD, FAAN, discusses the online learning opportunities offered by the AAN during the COVID-19 pandemic.

Duration: 14:49

Associated with:

Published on: 05.20.2020

COVID19–CNN Medical Correspondent Sanjay Gupta, MD, reports on what’s known to date.
COVID19–CNN Medical Correspondent Sanjay Gupta, MD, reports on what’s known to date.

Legend: COVID-19: CNN Chief Medical Correspondent Sanjay Gupta, MD, associate chief of neurosurgery at Grady Memorial Hospital in Atlanta, provides an overview of what’s known to date on COVID-19 with Richard S. Isaacson, MD, FAAN, of Weill Cornell Medicine. For complete Neurology Today complete coverage of COVID-19, visit https://journals.lww.com/neurotodayonline/topics/COVID-19

Duration: 23:46

Associated with:

Published on: 04.20.2020

Opioids Are Often Prescribed for Migraine Across All Age Groups
Opioids Are Often Prescribed for Migraine Across All Age Groups

Legend: Neurology Today At the American Headache Society Annual Meeting: Three different studies suggest that opioids are often prescribed to patients of all ages—ranging from 23 percent to 36.3 percent of the time—as a first-line therapy.

Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-opioids-migraine

Duration: 3:53

Associated with: Neurology Today. 19(16):1,24-30, August 22, 2019

Published on: 09.03.2019

Show: